Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eduardo Sotomayor

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Molecular Biotechnology|October 4, 2003
Gene therapy for lung cancerEric B Haura, Eduardo Sotomayor, Scott J Antonia
Methods in Molecular Medicine|November 1, 2002
Gene therapy for lung cancer. An introductionEric B Haura, Eduardo Sotomayor, Scott J Antonia
The Journal of Biological Chemistry|October 11, 2007
Histone deacetylase 3 down-regulates cholesterol synthesis through repression of lanosterol synthase gene expressionAlejandro Villagra, Natalia Ulloa, Xiaohong Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancerBin Yu, Sergei Kusmartsev, Fengdong Cheng, et al.
Cancer Research|August 9, 2003
All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccinationSergei Kusmartsev, Fengdong Cheng, Bin Yu, et al.
British Journal of Haematology|March 29, 2014
Prognostic significance of soft tissue extension, international prognostic index, and multifocality in primary bone lymphoma: a single institutional experienceHuanwen Wu, Ling Zhang, Haipeng Shao, et al.
Annals of Surgical Oncology|November 15, 2006
A phase-I trial using a universal GM-CSF-producing and CD40L-expressing bystander cell line (GM.CD40L) in the formulation of autologous tumor cell-based vaccines for cancer patients with stage IV diseaseSophie Dessureault, David Noyes, David Lee, et al.
Molecular Cancer Research : MCR|June 10, 2010
PRDM1 is required for mantle cell lymphoma response to bortezomibShruti Desai, Michelle Maurin, Matthew A Smith, et al.
Annals of Hematology|March 5, 2014
Serum albumin retains independent prognostic significance in diffuse large B-cell lymphoma in the post-rituximab eraSamir Dalia, Julio Chavez, Bryan Little, et al.
Blood|May 16, 2007
Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomasTint Lwin, Lori A Hazlehurst, Sophie Dessureault, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Molecular Biotechnology|October 4, 2003
Gene therapy for lung cancerEric B Haura, Eduardo Sotomayor, Scott J Antonia
Methods in Molecular Medicine|November 1, 2002
Gene therapy for lung cancer. An introductionEric B Haura, Eduardo Sotomayor, Scott J Antonia
The Journal of Biological Chemistry|October 11, 2007
Histone deacetylase 3 down-regulates cholesterol synthesis through repression of lanosterol synthase gene expressionAlejandro Villagra, Natalia Ulloa, Xiaohong Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancerBin Yu, Sergei Kusmartsev, Fengdong Cheng, et al.
Cancer Research|August 9, 2003
All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccinationSergei Kusmartsev, Fengdong Cheng, Bin Yu, et al.
British Journal of Haematology|March 29, 2014
Prognostic significance of soft tissue extension, international prognostic index, and multifocality in primary bone lymphoma: a single institutional experienceHuanwen Wu, Ling Zhang, Haipeng Shao, et al.
Annals of Surgical Oncology|November 15, 2006
A phase-I trial using a universal GM-CSF-producing and CD40L-expressing bystander cell line (GM.CD40L) in the formulation of autologous tumor cell-based vaccines for cancer patients with stage IV diseaseSophie Dessureault, David Noyes, David Lee, et al.
Molecular Cancer Research : MCR|June 10, 2010
PRDM1 is required for mantle cell lymphoma response to bortezomibShruti Desai, Michelle Maurin, Matthew A Smith, et al.
Annals of Hematology|March 5, 2014
Serum albumin retains independent prognostic significance in diffuse large B-cell lymphoma in the post-rituximab eraSamir Dalia, Julio Chavez, Bryan Little, et al.
Blood|May 16, 2007
Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomasTint Lwin, Lori A Hazlehurst, Sophie Dessureault, et al.
Pageof 3